Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $2.1B | -- | -- | $3.34 | -- |
| 10/29/2025 | Q3 | $2B | $1.9B | $6.98 | $3.08 | $3.90 |
| 07/30/2025 | Q2 | $2B | $1.8B | $7.09 | $2.68 | $4.41 |
| 04/30/2025 | Q1 | $2B | $2B | $3.48 | $2.80 | $0.69 |
| 02/26/2025 | Q4 | $2B | $2B | $3.52 | $2.57 | $0.95 |
| 10/30/2024 | Q3 | $1.9B | $1.9B | $2.00 | $2.42 | -$0.42 |
| 08/01/2024 | Q2 | $1.9B | $2B | $2.28 | $2.34 | -$0.06 |
| 05/01/2024 | Q1 | $1.9B | $2B | $3.02 | $2.39 | $0.63 |
| 02/23/2024 | Q4 | $1.9B | $1.9B | $5.13 | $2.45 | $2.68 |
| 10/27/2023 | Q3 | -- | -- | $4.86 | $2.39 | $2.47 |
| 07/31/2023 | Q2 | -- | -- | $2.12 | $2.06 | $0.06 |
| 05/02/2023 | Q1 | -- | -- | $1.79 | $2.03 | -$0.24 |
| 03/02/2023 | Q4 | -- | -- | $2.06 | $1.96 | $0.10 |
| 11/03/2022 | Q3 | -- | -- | $1.82 | $1.39 | $0.43 |
| 08/11/2022 | Q2 | -- | -- | $1.40 | $1.42 | -$0.02 |
| 05/17/2022 | Q1 | -- | -- | -$8.35 | $1.56 | -$9.91 |
| 03/30/2022 | Q4 | -- | -- | -$0.33 | $1.61 | -$1.94 |
| 11/10/2021 | Q3 | -- | -- | $3.35 | $3.47 | -$0.12 |
| 07/29/2021 | Q2 | -- | -- | $1.92 | -- | -- |
| 04/28/2021 | Q1 | -- | -- | $1.76 | $1.20 | $0.56 |
| 03/02/2021 | Q4 | -- | -- | $0.22 | $0.88 | -$0.66 |
| 11/10/2020 | Q3 | -- | -- | -$6.66 | $0.50 | -$7.16 |
| 07/29/2020 | Q2 | -- | -- | $1.92 | $1.40 | $0.52 |
| 05/05/2020 | Q1 | -- | -- | $2.14 | -- | -- |
| 02/13/2020 | Q4 | -- | -- | $2.33 | -- | -- |
| 11/08/2019 | Q3 | -- | -- | $2.01 | $1.90 | $0.11 |
| 07/30/2019 | Q2 | -- | -- | $2.09 | $1.68 | $0.42 |
| 05/01/2019 | Q1 | -- | -- | $1.58 | $1.61 | -$0.03 |
| 02/14/2019 | Q4 | -- | -- | $1.95 | $1.60 | $0.35 |
| 10/30/2018 | Q3 | -- | -- | $1.93 | $1.62 | $0.30 |
| 07/30/2018 | Q2 | -- | -- | $1.69 | $1.48 | $0.21 |
| 05/03/2018 | Q1 | -- | -- | $1.50 | $1.61 | -$0.10 |
| 02/14/2018 | Q4 | -- | -- | $1.64 | $1.38 | $0.26 |
| 11/02/2017 | Q3 | -- | -- | $1.87 | $1.61 | $0.26 |
| 08/03/2017 | Q2 | -- | -- | $1.90 | $1.50 | $0.39 |
| 05/09/2017 | Q1 | -- | -- | $1.42 | $1.46 | -$0.05 |
| 02/21/2017 | Q4 | -- | -- | $2.18 | $1.69 | $0.49 |
| 11/08/2016 | Q3 | -- | -- | $1.68 | $1.42 | $0.26 |
| 08/09/2016 | Q2 | -- | -- | $1.53 | $1.43 | $0.10 |
| 05/12/2016 | Q1 | -- | -- | $1.53 | $1.49 | $0.04 |
| 02/23/2016 | Q4 | -- | -- | $1.42 | $1.49 | -$0.07 |
AerCap Holdings NV reported $1.9B worth of top line sales in its most recent quarter.
AerCap Holdings NV announced earnings per share of $6.98 which represents a beat of analyst forecast a $3.08 per share.
AerCap Holdings NV reported $1.1B that represents $6.52 per share over the last quarter.
AerCap Holdings NV's earnings are forecast to grow from $10.79 per share to $11.11 per share next year representing an increase of 35.88%.
AerCap Holdings NV's next earnings date is February 25, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.